|
|
|
Volumn 161, Issue 6, 1998, Pages 3186-3194
|
|
Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
EPITOPE;
HLA A2 ANTIGEN;
OLIGOPEPTIDE;
PROSTATE SPECIFIC ANTIGEN;
PROTEINASE INHIBITOR;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER CELL CULTURE;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IMMUNE RESPONSE;
IMMUNOGENICITY;
MOUSE;
NONHUMAN;
PEPTIDE SYNTHESIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN EXPRESSION;
TARGET CELL;
AMINO ACID SEQUENCE;
ANIMALS;
CARCINOMA;
CELL CULTURE TECHNIQUES;
CYTOTOXICITY TESTS, IMMUNOLOGIC;
CYTOTOXICITY, IMMUNOLOGIC;
EPITOPES, T-LYMPHOCYTE;
HLA-A ANTIGENS;
HUMANS;
IMMUNODOMINANT EPITOPES;
LYMPHOCYTE ACTIVATION;
MALE;
MICE;
MICE, TRANSGENIC;
MOLECULAR SEQUENCE DATA;
OLIGOPEPTIDES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
PROTEASE INHIBITORS;
RECOMBINATION, GENETIC;
T-LYMPHOCYTES, CYTOTOXIC;
TUMOR CELLS, CULTURED;
VACCINIA VIRUS;
|
|
EID: 0032530575
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (119)
|
|
References (61)
|
